Titmus Stereopsis

The polarized glasses separate the image information reaching each eye: each eye views a slightly different version of the target. That difference, called binocular disparity, gives the visual cortex the paired signals needed to combine the views into a three-dimensional percept. If the two views are not effectively integrated, measured depth perception may be reduced or absent.

Target difficulty is central to the Titmus Stereo Test. Its Fly and animal or geometric figures are arranged as graded targets, allowing clinicians to examine performance across levels of disparity rather than relying on a single pass-or-fail image. The resulting stereoacuity estimate indicates how finely the patient can use binocular depth information during the assessment.

Reduced Titmus stereopsis can reflect disruption at more than one point in binocular vision. Ocular misalignment can prevent the two eyes from supplying appropriately coordinated views, while impaired visual processing can interfere with the brain’s integration of those views. This distinction matters clinically because an abnormal result can support evaluation for strabismus, amblyopia, or other binocular-vision disorders.

During a clinical assessment, the patient wears the test’s polarized glasses while viewing the presented targets. The clinician progresses through the available Fly and animal or geometric figures and uses the patient’s performance to estimate stereoacuity. The graded targets and polarization condition are central to delivering binocular disparity and evaluating how effectively the visual system combines the two views.

An abnormal score does not stand alone as a diagnosis. Instead, clinicians use reduced or absent stereoscopic vision as screening information when considering amblyopia, strabismus, and other disorders that affect ocular alignment or coordinated visual processing. The result therefore contributes to a broader clinical assessment, helping identify patients who may require closer evaluation of binocular vision.

Repeated testing can add a monitoring role to the assessment. When treatment is directed at a condition affecting binocular vision, changes in measured stereoacuity can help clinicians follow the outcome over time. This use does not replace clinical interpretation; it provides a structured comparison of binocular depth perception before and after management, supporting assessment of changes in visual function.